198 related articles for article (PubMed ID: 21211519)
1. Cord blood plasma reference intervals for potential sepsis markers: pro-adrenomedullin, pro-endothelin, and pro-atrial natriuretic peptide.
Miguel D; Prieto B; Costa M; Coto D; Alvarez FV
Clin Biochem; 2011 Mar; 44(4):337-41. PubMed ID: 21211519
[TBL] [Abstract][Full Text] [Related]
2. Stable precursor fragments of vasoactive peptides in umbilical cord blood of term and preterm infants.
Koch L; Dabek MT; Frommhold D; Poeschl J
Horm Res Paediatr; 2011; 76(4):234-9. PubMed ID: 21893934
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T;
Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
[TBL] [Abstract][Full Text] [Related]
6. Pro-adrenomedullin, pro-endothelin-1, procalcitonin, C-reactive protein and mortality risk in critically ill children: a prospective study.
Rey C; García-Hernández I; Concha A; Martínez-Camblor P; Botrán M; Medina A; Prieto B; López-Herce J
Crit Care; 2013 Oct; 17(5):R240. PubMed ID: 24131732
[TBL] [Abstract][Full Text] [Related]
7. Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis.
Llorente E; Prieto B; Cardo L; Avello N; Alvarez FV
Clin Chem Lab Med; 2007; 45(11):1531-5. PubMed ID: 17892436
[TBL] [Abstract][Full Text] [Related]
8. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.
Holm H; Nägga K; Nilsson ED; Ricci F; Melander O; Hansson O; Bachus E; Magnusson M; Fedorowski A
J Intern Med; 2017 Jul; 282(1):94-101. PubMed ID: 28407377
[TBL] [Abstract][Full Text] [Related]
10. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
Buerger K; Ernst A; Ewers M; Uspenskaya O; Omerovic M; Morgenthaler NG; Knauer K; Bergmann A; Hampel H
Biol Psychiatry; 2009 Jun; 65(11):979-84. PubMed ID: 19344890
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular biomarkers in preeclampsia at triage.
Wellmann S; Benzing J; Fleischlin S; Morgenthaler N; Fouzas S; Bührer CA; Szinnai G; Burkhardt T; Lapaire O
Fetal Diagn Ther; 2014; 36(3):202-7. PubMed ID: 24853905
[TBL] [Abstract][Full Text] [Related]
12. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
[TBL] [Abstract][Full Text] [Related]
13. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
14. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
Heining L; Giesa C; Ewig S
Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
[TBL] [Abstract][Full Text] [Related]
15. Precursors of adrenomedullin, endothelin and atrial natriuretic peptide as diagnostic markers of neonatal infection.
Cao Y; Xia Q; Chen C; Yang Y
Acta Paediatr; 2012 Mar; 101(3):242-6. PubMed ID: 22053979
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session.
Mueller T; Gegenhuber A; Kronabethleitner G; Leitner I; Haltmayer M; Dieplinger B
Clin Biochem; 2015 Nov; 48(16-17):1163-6. PubMed ID: 26232288
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis.
Angeletti S; Battistoni F; Fioravanti M; Bernardini S; Dicuonzo G
Clin Chem Lab Med; 2013 May; 51(5):1059-67. PubMed ID: 23072859
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin as a biomarker for early sepsis in the emergency department.
Hicks CW; Engineer RS; Benoit JL; Dasarathy S; Christenson RH; Peacock WF
Eur J Emerg Med; 2014 Apr; 21(2):112-7. PubMed ID: 23669296
[TBL] [Abstract][Full Text] [Related]
19. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
